Merus Announces Recent Corporate Developments and Financial Results for the First Quarter 2018 Read more about Merus Announces Recent Corporate Developments and Financial Results for the First Quarter 2018
Merus Announces Annual Meeting of Shareholders Read more about Merus Announces Annual Meeting of Shareholders
Merus to Present at the Jefferies 2018 Healthcare Conference Read more about Merus to Present at the Jefferies 2018 Healthcare Conference
Merus Announces First Patient Dosed in Phase 1 Clinical Trial of MCLA-158 in Patients with Solid Tumors Read more about Merus Announces First Patient Dosed in Phase 1 Clinical Trial of MCLA-158 in Patients with Solid Tumors
Merus Announces Unique Mechanism of Action of MCLA-128 That Potently Blocks HER3 Signaling Published in Cancer Cell Read more about Merus Announces Unique Mechanism of Action of MCLA-128 That Potently Blocks HER3 Signaling Published in Cancer Cell
Merus to Report Full Year 2017 Financial Results and Corporate Developments on April 26, 2018 Read more about Merus to Report Full Year 2017 Financial Results and Corporate Developments on April 26, 2018
Merus and the Vall d’Hebron Institute of Oncology Announce Research Collaboration to Develop Innovative Bispecific Antibodies for Therapeutic Applications in the Treatment of Cancer Read more about Merus and the Vall d’Hebron Institute of Oncology Announce Research Collaboration to Develop Innovative Bispecific Antibodies for Therapeutic Applications in the Treatment of Cancer
Merus Announces Ono Pharmaceuticals Exercise of its Option for New Research and License Agreement to Generate Bispecific Antibody Targeting Autoimmune Diseases Read more about Merus Announces Ono Pharmaceuticals Exercise of its Option for New Research and License Agreement to Generate Bispecific Antibody Targeting Autoimmune Diseases
Merus’ Intellectual Property Portfolio Expands with Two New Patents Read more about Merus’ Intellectual Property Portfolio Expands with Two New Patents
Merus to Present at the Cowen & Co. 38th Annual Health Care Conference Read more about Merus to Present at the Cowen & Co. 38th Annual Health Care Conference